0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Intramuscular Injectable Suspensions Market Research Report 2024
Published Date: February 2024
|
Report Code: QYRE-Auto-21L9351
Home | Market Reports | Health| Health Foundations & Medical Research
Global Intramuscular Injectable Suspensions Market Research Report 2022
BUY CHAPTERS

Global Intramuscular Injectable Suspensions Market Research Report 2024

Code: QYRE-Auto-21L9351
Report
February 2024
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Intramuscular Injectable Suspensions Market

The global Intramuscular Injectable Suspensions market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Intramuscular Injectable Suspensions is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Intramuscular Injectable Suspensions is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Intramuscular Injectable Suspensions include Merck Sharp & Dohme, Novo Nordisk, Lilly, Biocon Limited, Pfizer, BeiGene, EnteraBio, AbbVie and Pfizer Limited, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Intramuscular Injectable Suspensions, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intramuscular Injectable Suspensions.

Report Scope

The Intramuscular Injectable Suspensions market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Intramuscular Injectable Suspensions market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intramuscular Injectable Suspensions manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Intramuscular Injectable Suspensions Market Report

Report Metric Details
Report Name Intramuscular Injectable Suspensions Market
Segment by Type
  • Single-Dose Injections
  • Multiple-Dose Injections
Segment by Application
  • Hospitals Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck Sharp & Dohme, Novo Nordisk, Lilly, Biocon Limited, Pfizer, BeiGene, EnteraBio, AbbVie, Pfizer Limited, Teva Pharmaceuticals USA, Bristol-Myers Squibb, Cipla, Baxter International, AstraZeneca
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Intramuscular Injectable Suspensions manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Intramuscular Injectable Suspensions in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Intramuscular Injectable Suspensions Market report?

Ans: The main players in the Intramuscular Injectable Suspensions Market are Merck Sharp & Dohme, Novo Nordisk, Lilly, Biocon Limited, Pfizer, BeiGene, EnteraBio, AbbVie, Pfizer Limited, Teva Pharmaceuticals USA, Bristol-Myers Squibb, Cipla, Baxter International, AstraZeneca

What are the Application segmentation covered in the Intramuscular Injectable Suspensions Market report?

Ans: The Applications covered in the Intramuscular Injectable Suspensions Market report are Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Intramuscular Injectable Suspensions Market report?

Ans: The Types covered in the Intramuscular Injectable Suspensions Market report are Single-Dose Injections, Multiple-Dose Injections

1 Intramuscular Injectable Suspensions Market Overview
1.1 Product Overview and Scope of Intramuscular Injectable Suspensions
1.2 Intramuscular Injectable Suspensions Segment by Type
1.2.1 Global Intramuscular Injectable Suspensions Market Value Comparison by Type (2024-2030)
1.2.2 Single-Dose Injections
1.2.3 Multiple-Dose Injections
1.3 Intramuscular Injectable Suspensions Segment by Application
1.3.1 Global Intramuscular Injectable Suspensions Market Value by Application: (2024-2030)
1.3.2 Hospitals Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Intramuscular Injectable Suspensions Market Size Estimates and Forecasts
1.4.1 Global Intramuscular Injectable Suspensions Revenue 2019-2030
1.4.2 Global Intramuscular Injectable Suspensions Sales 2019-2030
1.4.3 Global Intramuscular Injectable Suspensions Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Intramuscular Injectable Suspensions Market Competition by Manufacturers
2.1 Global Intramuscular Injectable Suspensions Sales Market Share by Manufacturers (2019-2024)
2.2 Global Intramuscular Injectable Suspensions Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Intramuscular Injectable Suspensions Average Price by Manufacturers (2019-2024)
2.4 Global Intramuscular Injectable Suspensions Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Intramuscular Injectable Suspensions, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Intramuscular Injectable Suspensions, Product Type & Application
2.7 Intramuscular Injectable Suspensions Market Competitive Situation and Trends
2.7.1 Intramuscular Injectable Suspensions Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Intramuscular Injectable Suspensions Players Market Share by Revenue
2.7.3 Global Intramuscular Injectable Suspensions Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Intramuscular Injectable Suspensions Retrospective Market Scenario by Region
3.1 Global Intramuscular Injectable Suspensions Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Intramuscular Injectable Suspensions Global Intramuscular Injectable Suspensions Sales by Region: 2019-2030
3.2.1 Global Intramuscular Injectable Suspensions Sales by Region: 2019-2024
3.2.2 Global Intramuscular Injectable Suspensions Sales by Region: 2025-2030
3.3 Global Intramuscular Injectable Suspensions Global Intramuscular Injectable Suspensions Revenue by Region: 2019-2030
3.3.1 Global Intramuscular Injectable Suspensions Revenue by Region: 2019-2024
3.3.2 Global Intramuscular Injectable Suspensions Revenue by Region: 2025-2030
3.4 North America Intramuscular Injectable Suspensions Market Facts & Figures by Country
3.4.1 North America Intramuscular Injectable Suspensions Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Intramuscular Injectable Suspensions Sales by Country (2019-2030)
3.4.3 North America Intramuscular Injectable Suspensions Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Intramuscular Injectable Suspensions Market Facts & Figures by Country
3.5.1 Europe Intramuscular Injectable Suspensions Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Intramuscular Injectable Suspensions Sales by Country (2019-2030)
3.5.3 Europe Intramuscular Injectable Suspensions Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Intramuscular Injectable Suspensions Market Facts & Figures by Country
3.6.1 Asia Pacific Intramuscular Injectable Suspensions Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Intramuscular Injectable Suspensions Sales by Country (2019-2030)
3.6.3 Asia Pacific Intramuscular Injectable Suspensions Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Intramuscular Injectable Suspensions Market Facts & Figures by Country
3.7.1 Latin America Intramuscular Injectable Suspensions Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Intramuscular Injectable Suspensions Sales by Country (2019-2030)
3.7.3 Latin America Intramuscular Injectable Suspensions Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Intramuscular Injectable Suspensions Market Facts & Figures by Country
3.8.1 Middle East and Africa Intramuscular Injectable Suspensions Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Intramuscular Injectable Suspensions Sales by Country (2019-2030)
3.8.3 Middle East and Africa Intramuscular Injectable Suspensions Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Intramuscular Injectable Suspensions Sales by Type (2019-2030)
4.1.1 Global Intramuscular Injectable Suspensions Sales by Type (2019-2024)
4.1.2 Global Intramuscular Injectable Suspensions Sales by Type (2025-2030)
4.1.3 Global Intramuscular Injectable Suspensions Sales Market Share by Type (2019-2030)
4.2 Global Intramuscular Injectable Suspensions Revenue by Type (2019-2030)
4.2.1 Global Intramuscular Injectable Suspensions Revenue by Type (2019-2024)
4.2.2 Global Intramuscular Injectable Suspensions Revenue by Type (2025-2030)
4.2.3 Global Intramuscular Injectable Suspensions Revenue Market Share by Type (2019-2030)
4.3 Global Intramuscular Injectable Suspensions Price by Type (2019-2030)
5 Segment by Application
5.1 Global Intramuscular Injectable Suspensions Sales by Application (2019-2030)
5.1.1 Global Intramuscular Injectable Suspensions Sales by Application (2019-2024)
5.1.2 Global Intramuscular Injectable Suspensions Sales by Application (2025-2030)
5.1.3 Global Intramuscular Injectable Suspensions Sales Market Share by Application (2019-2030)
5.2 Global Intramuscular Injectable Suspensions Revenue by Application (2019-2030)
5.2.1 Global Intramuscular Injectable Suspensions Revenue by Application (2019-2024)
5.2.2 Global Intramuscular Injectable Suspensions Revenue by Application (2025-2030)
5.2.3 Global Intramuscular Injectable Suspensions Revenue Market Share by Application (2019-2030)
5.3 Global Intramuscular Injectable Suspensions Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck Sharp & Dohme
6.1.1 Merck Sharp & Dohme Corporation Information
6.1.2 Merck Sharp & Dohme Description and Business Overview
6.1.3 Merck Sharp & Dohme Intramuscular Injectable Suspensions Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck Sharp & Dohme Intramuscular Injectable Suspensions Product Portfolio
6.1.5 Merck Sharp & Dohme Recent Developments/Updates
6.2 Novo Nordisk
6.2.1 Novo Nordisk Corporation Information
6.2.2 Novo Nordisk Description and Business Overview
6.2.3 Novo Nordisk Intramuscular Injectable Suspensions Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Novo Nordisk Intramuscular Injectable Suspensions Product Portfolio
6.2.5 Novo Nordisk Recent Developments/Updates
6.3 Lilly
6.3.1 Lilly Corporation Information
6.3.2 Lilly Description and Business Overview
6.3.3 Lilly Intramuscular Injectable Suspensions Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Lilly Intramuscular Injectable Suspensions Product Portfolio
6.3.5 Lilly Recent Developments/Updates
6.4 Biocon Limited
6.4.1 Biocon Limited Corporation Information
6.4.2 Biocon Limited Description and Business Overview
6.4.3 Biocon Limited Intramuscular Injectable Suspensions Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Biocon Limited Intramuscular Injectable Suspensions Product Portfolio
6.4.5 Biocon Limited Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Corporation Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer Intramuscular Injectable Suspensions Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Pfizer Intramuscular Injectable Suspensions Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 BeiGene
6.6.1 BeiGene Corporation Information
6.6.2 BeiGene Description and Business Overview
6.6.3 BeiGene Intramuscular Injectable Suspensions Sales, Revenue and Gross Margin (2019-2024)
6.6.4 BeiGene Intramuscular Injectable Suspensions Product Portfolio
6.6.5 BeiGene Recent Developments/Updates
6.7 EnteraBio
6.6.1 EnteraBio Corporation Information
6.6.2 EnteraBio Description and Business Overview
6.6.3 EnteraBio Intramuscular Injectable Suspensions Sales, Revenue and Gross Margin (2019-2024)
6.4.4 EnteraBio Intramuscular Injectable Suspensions Product Portfolio
6.7.5 EnteraBio Recent Developments/Updates
6.8 AbbVie
6.8.1 AbbVie Corporation Information
6.8.2 AbbVie Description and Business Overview
6.8.3 AbbVie Intramuscular Injectable Suspensions Sales, Revenue and Gross Margin (2019-2024)
6.8.4 AbbVie Intramuscular Injectable Suspensions Product Portfolio
6.8.5 AbbVie Recent Developments/Updates
6.9 Pfizer Limited
6.9.1 Pfizer Limited Corporation Information
6.9.2 Pfizer Limited Description and Business Overview
6.9.3 Pfizer Limited Intramuscular Injectable Suspensions Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Pfizer Limited Intramuscular Injectable Suspensions Product Portfolio
6.9.5 Pfizer Limited Recent Developments/Updates
6.10 Teva Pharmaceuticals USA
6.10.1 Teva Pharmaceuticals USA Corporation Information
6.10.2 Teva Pharmaceuticals USA Description and Business Overview
6.10.3 Teva Pharmaceuticals USA Intramuscular Injectable Suspensions Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Teva Pharmaceuticals USA Intramuscular Injectable Suspensions Product Portfolio
6.10.5 Teva Pharmaceuticals USA Recent Developments/Updates
6.11 Bristol-Myers Squibb
6.11.1 Bristol-Myers Squibb Corporation Information
6.11.2 Bristol-Myers Squibb Intramuscular Injectable Suspensions Description and Business Overview
6.11.3 Bristol-Myers Squibb Intramuscular Injectable Suspensions Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Bristol-Myers Squibb Intramuscular Injectable Suspensions Product Portfolio
6.11.5 Bristol-Myers Squibb Recent Developments/Updates
6.12 Cipla
6.12.1 Cipla Corporation Information
6.12.2 Cipla Intramuscular Injectable Suspensions Description and Business Overview
6.12.3 Cipla Intramuscular Injectable Suspensions Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Cipla Intramuscular Injectable Suspensions Product Portfolio
6.12.5 Cipla Recent Developments/Updates
6.13 Baxter International
6.13.1 Baxter International Corporation Information
6.13.2 Baxter International Intramuscular Injectable Suspensions Description and Business Overview
6.13.3 Baxter International Intramuscular Injectable Suspensions Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Baxter International Intramuscular Injectable Suspensions Product Portfolio
6.13.5 Baxter International Recent Developments/Updates
6.14 AstraZeneca
6.14.1 AstraZeneca Corporation Information
6.14.2 AstraZeneca Intramuscular Injectable Suspensions Description and Business Overview
6.14.3 AstraZeneca Intramuscular Injectable Suspensions Sales, Revenue and Gross Margin (2019-2024)
6.14.4 AstraZeneca Intramuscular Injectable Suspensions Product Portfolio
6.14.5 AstraZeneca Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Intramuscular Injectable Suspensions Industry Chain Analysis
7.2 Intramuscular Injectable Suspensions Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Intramuscular Injectable Suspensions Production Mode & Process
7.4 Intramuscular Injectable Suspensions Sales and Marketing
7.4.1 Intramuscular Injectable Suspensions Sales Channels
7.4.2 Intramuscular Injectable Suspensions Distributors
7.5 Intramuscular Injectable Suspensions Customers
8 Intramuscular Injectable Suspensions Market Dynamics
8.1 Intramuscular Injectable Suspensions Industry Trends
8.2 Intramuscular Injectable Suspensions Market Drivers
8.3 Intramuscular Injectable Suspensions Market Challenges
8.4 Intramuscular Injectable Suspensions Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Intramuscular Injectable Suspensions Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Intramuscular Injectable Suspensions Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Intramuscular Injectable Suspensions Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Intramuscular Injectable Suspensions Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Intramuscular Injectable Suspensions Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Intramuscular Injectable Suspensions Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Intramuscular Injectable Suspensions Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Intramuscular Injectable Suspensions Average Price (US$/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Intramuscular Injectable Suspensions, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Intramuscular Injectable Suspensions, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Intramuscular Injectable Suspensions, Product Type & Application
    Table 12. Global Key Manufacturers of Intramuscular Injectable Suspensions, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Intramuscular Injectable Suspensions by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intramuscular Injectable Suspensions as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Intramuscular Injectable Suspensions Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Intramuscular Injectable Suspensions Sales by Region (2019-2024) & (K Units)
    Table 18. Global Intramuscular Injectable Suspensions Sales Market Share by Region (2019-2024)
    Table 19. Global Intramuscular Injectable Suspensions Sales by Region (2025-2030) & (K Units)
    Table 20. Global Intramuscular Injectable Suspensions Sales Market Share by Region (2025-2030)
    Table 21. Global Intramuscular Injectable Suspensions Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Intramuscular Injectable Suspensions Revenue Market Share by Region (2019-2024)
    Table 23. Global Intramuscular Injectable Suspensions Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Intramuscular Injectable Suspensions Revenue Market Share by Region (2025-2030)
    Table 25. North America Intramuscular Injectable Suspensions Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Intramuscular Injectable Suspensions Sales by Country (2019-2024) & (K Units)
    Table 27. North America Intramuscular Injectable Suspensions Sales by Country (2025-2030) & (K Units)
    Table 28. North America Intramuscular Injectable Suspensions Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Intramuscular Injectable Suspensions Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Intramuscular Injectable Suspensions Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Intramuscular Injectable Suspensions Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Intramuscular Injectable Suspensions Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Intramuscular Injectable Suspensions Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Intramuscular Injectable Suspensions Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Intramuscular Injectable Suspensions Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Intramuscular Injectable Suspensions Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Intramuscular Injectable Suspensions Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Intramuscular Injectable Suspensions Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Intramuscular Injectable Suspensions Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Intramuscular Injectable Suspensions Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Intramuscular Injectable Suspensions Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Intramuscular Injectable Suspensions Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Intramuscular Injectable Suspensions Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Intramuscular Injectable Suspensions Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Intramuscular Injectable Suspensions Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Intramuscular Injectable Suspensions Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Intramuscular Injectable Suspensions Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Intramuscular Injectable Suspensions Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Intramuscular Injectable Suspensions Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Intramuscular Injectable Suspensions Sales (K Units) by Type (2019-2024)
    Table 51. Global Intramuscular Injectable Suspensions Sales (K Units) by Type (2025-2030)
    Table 52. Global Intramuscular Injectable Suspensions Sales Market Share by Type (2019-2024)
    Table 53. Global Intramuscular Injectable Suspensions Sales Market Share by Type (2025-2030)
    Table 54. Global Intramuscular Injectable Suspensions Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Intramuscular Injectable Suspensions Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Intramuscular Injectable Suspensions Revenue Market Share by Type (2019-2024)
    Table 57. Global Intramuscular Injectable Suspensions Revenue Market Share by Type (2025-2030)
    Table 58. Global Intramuscular Injectable Suspensions Price (US$/Unit) by Type (2019-2024)
    Table 59. Global Intramuscular Injectable Suspensions Price (US$/Unit) by Type (2025-2030)
    Table 60. Global Intramuscular Injectable Suspensions Sales (K Units) by Application (2019-2024)
    Table 61. Global Intramuscular Injectable Suspensions Sales (K Units) by Application (2025-2030)
    Table 62. Global Intramuscular Injectable Suspensions Sales Market Share by Application (2019-2024)
    Table 63. Global Intramuscular Injectable Suspensions Sales Market Share by Application (2025-2030)
    Table 64. Global Intramuscular Injectable Suspensions Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Intramuscular Injectable Suspensions Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Intramuscular Injectable Suspensions Revenue Market Share by Application (2019-2024)
    Table 67. Global Intramuscular Injectable Suspensions Revenue Market Share by Application (2025-2030)
    Table 68. Global Intramuscular Injectable Suspensions Price (US$/Unit) by Application (2019-2024)
    Table 69. Global Intramuscular Injectable Suspensions Price (US$/Unit) by Application (2025-2030)
    Table 70. Merck Sharp & Dohme Corporation Information
    Table 71. Merck Sharp & Dohme Description and Business Overview
    Table 72. Merck Sharp & Dohme Intramuscular Injectable Suspensions Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 73. Merck Sharp & Dohme Intramuscular Injectable Suspensions Product
    Table 74. Merck Sharp & Dohme Recent Developments/Updates
    Table 75. Novo Nordisk Corporation Information
    Table 76. Novo Nordisk Description and Business Overview
    Table 77. Novo Nordisk Intramuscular Injectable Suspensions Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 78. Novo Nordisk Intramuscular Injectable Suspensions Product
    Table 79. Novo Nordisk Recent Developments/Updates
    Table 80. Lilly Corporation Information
    Table 81. Lilly Description and Business Overview
    Table 82. Lilly Intramuscular Injectable Suspensions Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 83. Lilly Intramuscular Injectable Suspensions Product
    Table 84. Lilly Recent Developments/Updates
    Table 85. Biocon Limited Corporation Information
    Table 86. Biocon Limited Description and Business Overview
    Table 87. Biocon Limited Intramuscular Injectable Suspensions Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 88. Biocon Limited Intramuscular Injectable Suspensions Product
    Table 89. Biocon Limited Recent Developments/Updates
    Table 90. Pfizer Corporation Information
    Table 91. Pfizer Description and Business Overview
    Table 92. Pfizer Intramuscular Injectable Suspensions Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 93. Pfizer Intramuscular Injectable Suspensions Product
    Table 94. Pfizer Recent Developments/Updates
    Table 95. BeiGene Corporation Information
    Table 96. BeiGene Description and Business Overview
    Table 97. BeiGene Intramuscular Injectable Suspensions Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 98. BeiGene Intramuscular Injectable Suspensions Product
    Table 99. BeiGene Recent Developments/Updates
    Table 100. EnteraBio Corporation Information
    Table 101. EnteraBio Description and Business Overview
    Table 102. EnteraBio Intramuscular Injectable Suspensions Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 103. EnteraBio Intramuscular Injectable Suspensions Product
    Table 104. EnteraBio Recent Developments/Updates
    Table 105. AbbVie Corporation Information
    Table 106. AbbVie Description and Business Overview
    Table 107. AbbVie Intramuscular Injectable Suspensions Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 108. AbbVie Intramuscular Injectable Suspensions Product
    Table 109. AbbVie Recent Developments/Updates
    Table 110. Pfizer Limited Corporation Information
    Table 111. Pfizer Limited Description and Business Overview
    Table 112. Pfizer Limited Intramuscular Injectable Suspensions Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 113. Pfizer Limited Intramuscular Injectable Suspensions Product
    Table 114. Pfizer Limited Recent Developments/Updates
    Table 115. Teva Pharmaceuticals USA Corporation Information
    Table 116. Teva Pharmaceuticals USA Description and Business Overview
    Table 117. Teva Pharmaceuticals USA Intramuscular Injectable Suspensions Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 118. Teva Pharmaceuticals USA Intramuscular Injectable Suspensions Product
    Table 119. Teva Pharmaceuticals USA Recent Developments/Updates
    Table 120. Bristol-Myers Squibb Corporation Information
    Table 121. Bristol-Myers Squibb Description and Business Overview
    Table 122. Bristol-Myers Squibb Intramuscular Injectable Suspensions Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 123. Bristol-Myers Squibb Intramuscular Injectable Suspensions Product
    Table 124. Bristol-Myers Squibb Recent Developments/Updates
    Table 125. Cipla Corporation Information
    Table 126. Cipla Description and Business Overview
    Table 127. Cipla Intramuscular Injectable Suspensions Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 128. Cipla Intramuscular Injectable Suspensions Product
    Table 129. Cipla Recent Developments/Updates
    Table 130. Baxter International Corporation Information
    Table 131. Baxter International Description and Business Overview
    Table 132. Baxter International Intramuscular Injectable Suspensions Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 133. Baxter International Intramuscular Injectable Suspensions Product
    Table 134. Baxter International Recent Developments/Updates
    Table 135. AstraZeneca Corporation Information
    Table 136. AstraZeneca Description and Business Overview
    Table 137. AstraZeneca Intramuscular Injectable Suspensions Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 138. AstraZeneca Intramuscular Injectable Suspensions Product
    Table 139. AstraZeneca Recent Developments/Updates
    Table 140. Key Raw Materials Lists
    Table 141. Raw Materials Key Suppliers Lists
    Table 142. Intramuscular Injectable Suspensions Distributors List
    Table 143. Intramuscular Injectable Suspensions Customers List
    Table 144. Intramuscular Injectable Suspensions Market Trends
    Table 145. Intramuscular Injectable Suspensions Market Drivers
    Table 146. Intramuscular Injectable Suspensions Market Challenges
    Table 147. Intramuscular Injectable Suspensions Market Restraints
    Table 148. Research Programs/Design for This Report
    Table 149. Key Data Information from Secondary Sources
    Table 150. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Intramuscular Injectable Suspensions
    Figure 2. Global Intramuscular Injectable Suspensions Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Intramuscular Injectable Suspensions Market Share by Type in 2023 & 2030
    Figure 4. Single-Dose Injections Product Picture
    Figure 5. Multiple-Dose Injections Product Picture
    Figure 6. Global Intramuscular Injectable Suspensions Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 7. Global Intramuscular Injectable Suspensions Market Share by Application in 2023 & 2030
    Figure 8. Hospitals Pharmacies
    Figure 9. Retail Pharmacies
    Figure 10. Online Pharmacies
    Figure 11. Global Intramuscular Injectable Suspensions Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 12. Global Intramuscular Injectable Suspensions Market Size (2019-2030) & (US$ Million)
    Figure 13. Global Intramuscular Injectable Suspensions Sales (2019-2030) & (K Units)
    Figure 14. Global Intramuscular Injectable Suspensions Average Price (US$/Unit) & (2019-2030)
    Figure 15. Intramuscular Injectable Suspensions Report Years Considered
    Figure 16. Intramuscular Injectable Suspensions Sales Share by Manufacturers in 2023
    Figure 17. Global Intramuscular Injectable Suspensions Revenue Share by Manufacturers in 2023
    Figure 18. The Global 5 and 10 Largest Intramuscular Injectable Suspensions Players: Market Share by Revenue in 2023
    Figure 19. Intramuscular Injectable Suspensions Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 20. Global Intramuscular Injectable Suspensions Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 21. North America Intramuscular Injectable Suspensions Sales Market Share by Country (2019-2030)
    Figure 22. North America Intramuscular Injectable Suspensions Revenue Market Share by Country (2019-2030)
    Figure 23. United States Intramuscular Injectable Suspensions Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 24. Canada Intramuscular Injectable Suspensions Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 25. Europe Intramuscular Injectable Suspensions Sales Market Share by Country (2019-2030)
    Figure 26. Europe Intramuscular Injectable Suspensions Revenue Market Share by Country (2019-2030)
    Figure 27. Germany Intramuscular Injectable Suspensions Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 28. France Intramuscular Injectable Suspensions Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. U.K. Intramuscular Injectable Suspensions Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. Italy Intramuscular Injectable Suspensions Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Russia Intramuscular Injectable Suspensions Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. Asia Pacific Intramuscular Injectable Suspensions Sales Market Share by Region (2019-2030)
    Figure 33. Asia Pacific Intramuscular Injectable Suspensions Revenue Market Share by Region (2019-2030)
    Figure 34. China Intramuscular Injectable Suspensions Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. Japan Intramuscular Injectable Suspensions Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. South Korea Intramuscular Injectable Suspensions Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. India Intramuscular Injectable Suspensions Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. Australia Intramuscular Injectable Suspensions Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. China Taiwan Intramuscular Injectable Suspensions Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Indonesia Intramuscular Injectable Suspensions Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Thailand Intramuscular Injectable Suspensions Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Malaysia Intramuscular Injectable Suspensions Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Latin America Intramuscular Injectable Suspensions Sales Market Share by Country (2019-2030)
    Figure 44. Latin America Intramuscular Injectable Suspensions Revenue Market Share by Country (2019-2030)
    Figure 45. Mexico Intramuscular Injectable Suspensions Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 46. Brazil Intramuscular Injectable Suspensions Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Argentina Intramuscular Injectable Suspensions Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Middle East & Africa Intramuscular Injectable Suspensions Sales Market Share by Country (2019-2030)
    Figure 49. Middle East & Africa Intramuscular Injectable Suspensions Revenue Market Share by Country (2019-2030)
    Figure 50. Turkey Intramuscular Injectable Suspensions Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 51. Saudi Arabia Intramuscular Injectable Suspensions Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. UAE Intramuscular Injectable Suspensions Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. Global Sales Market Share of Intramuscular Injectable Suspensions by Type (2019-2030)
    Figure 54. Global Revenue Market Share of Intramuscular Injectable Suspensions by Type (2019-2030)
    Figure 55. Global Intramuscular Injectable Suspensions Price (US$/Unit) by Type (2019-2030)
    Figure 56. Global Sales Market Share of Intramuscular Injectable Suspensions by Application (2019-2030)
    Figure 57. Global Revenue Market Share of Intramuscular Injectable Suspensions by Application (2019-2030)
    Figure 58. Global Intramuscular Injectable Suspensions Price (US$/Unit) by Application (2019-2030)
    Figure 59. Intramuscular Injectable Suspensions Value Chain
    Figure 60. Intramuscular Injectable Suspensions Production Process
    Figure 61. Channels of Distribution (Direct Vs Distribution)
    Figure 62. Distributors Profiles
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Clinical Data Management and Statistical Analysis Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-38E10402
Sun Apr 07 00:00:00 UTC 2024

Add to Cart

Global Cancer Tumor Profiling Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-6B2891
Tue Apr 02 00:00:00 UTC 2024

Add to Cart

Receptive Cell - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-34N12630
Tue Mar 26 00:00:00 UTC 2024

Add to Cart

Adipose Tissue Derived Stem Cell - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-8X13846
Tue Mar 26 00:00:00 UTC 2024

Add to Cart